JinMi Kim is an experienced R&D leader with over 20 years in the pharmaceutical industry, currently serving as the Head of Pfizer Oncology Research Portfolio Strategy & Scientific Operation. They have a broad background in drug discovery and development across various therapeutic areas, including Oncology and Cancer Immunology. Previously, Kim held several key positions at Boehringer Ingelheim and Seagen, contributing to strategic operations and project management. JinMi earned a Ph.D. in Organic Chemistry from the University of Ottawa, alongside a Master's from Dalhousie University and postdoctoral training at the University of California, Berkeley.
This person is not in any teams
This person is not in any offices